Cassaday & Co Wealth Management’s Hologic HOLX Stock Holding History

Cassaday & Co Wealth Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,579	Closed	-$195K	–	1361
2026 Q1	$195K	Buy	+2,579	New	+$194K	﹤0.01%	344
2024 Q4	–	Sell	-2,582	Closed	-$210K	–	327
2024 Q3	$210K	Buy	+2,582	New	+$207K	0.01%	296
2024 Q2	–	Sell	-2,579	Closed	-$201K	–	301
2024 Q1	$201K	Buy	+2,579	New	+$192K	0.01%	282
2023 Q2	–	Sell	-2,579	Closed	-$208K	–	262
2023 Q1	$208K	Sell	2,579 -200	-7%	-$16.1K	0.01%	248
2022 Q4	$208K	Buy	+2,779	New	+$198K	0.01%	237

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cassaday & Co Wealth Management's HOLX Position: Q2 2026 in Review

Cassaday & Co Wealth Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,579 shares — an estimated $195K sold.

Cassaday & Co Wealth Management first reported a position in HOLX in Q4 2022 and held it in 5 quarters. The position peaked at $210K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Cassaday & Co Wealth Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Cassaday & Co Wealth Management sold 2,579 Hologic shares in Q2 2026, an estimated $195K.
Cassaday & Co Wealth Management first reported a position in Hologic in Q4 2022 and held it in 5 quarters.
Cassaday & Co Wealth Management's Hologic position peaked at $210K in Q3 2024.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.